Prognosis
Teva to Settle Mississippi Drug-Price Case, Seek More Pacts
- Israeli company says it has agreed to pay U.S. state $925,000
- States sued Teva and others over claims of fixing drug prices
Photographer: Chris Ratcliffe/Bloomberg
This article is for subscribers only.
Teva Pharmaceutical Industries Ltd. said it had agreed to pay the state of Mississippi $925,000 to resolve claims that the company fixed prices of generic drugs, and that it is discussing potential pacts with other states.
In 2019, Mississippi was part of a large group of U.S. states that sued Israel-based Teva and other generic-drug makers, alleging a conspiracy to divide up customers and increase the cost of certain medications.